1-3 of 3
Xinan Lu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of a BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <3 Days Using the High-Performance Platform

Hui Liu, Ting Wang, Yazi Yang, Ru Feng, Jiangtao Li, Chunli Zhang, Jiefei Bai, Yanping Ding, Guanghua Liu, Fei Wu, Xinan Lu, Jian Li, Ting He
Journal: Blood
Blood (2022) 140 (Supplement 1): 10307–10308.
https://doi.org/10.1182/blood-2022-166011
Published: 2022
Journal Articles

Factors Predicting Long-Term Survival Following CD19 CAR T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Xian Zhang, MD, Junfang Yang, Wenqian Li, Gailing Zhang, MD, Yunchao Su, Yanze Shi, Dan Song, Min Zhang, Jiujiang He, Li Xu, Jingjing Li, Xinan Lu, Jianqiang Li, PhD, Xiangqun Li, Zhongwei Xu, Ziyu Li, Peihua Lu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-136897
Published: 2020
Journal Articles

Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways

Yang Chen, Shan Wang, Xinan Lu, Haoran Zhang, Yan Fu, Yongzhang Luo
Journal: Blood
Blood (2011) 117 (23): 6392–6403.
https://doi.org/10.1182/blood-2010-12-322867
Published: 2011
Includes: Supplemental data